Care transition from a pediatric intestinal rehabilitation program to adult care and the risk of all-cause mortality: A retrospective cohort study

Who's speaking

• Dr. Julian Goddard — host

Chapters

• 0:00Introduction: Survival Advances and Transition Risk — Introduction establishing improved survival for children with intestinal failure but highlighting transition to adult care as a dangerous period.
• 0:09Study Design and Population — Dr. Goddard introduces himself and describes the retrospective cohort study of 46 patients tracked at age 20 transition point.
• 0:23Key Findings: Mortality Disparity — Presentation of core findings showing 33% vs 5% mortality rates and 12-month median time to death post-transition.
• 0:46Clinical Implications — Discussion of vulnerable population status and need for structured transition programs.

Key claims

• 0:00Advances in medicine have dramatically improved survival rates for children with intestinal failure — Dr. Julian Goddard
• 0:13The study tracked 46 patients who turned 20 to evaluate outcomes during care transition — Dr. Julian Goddard
• 0:2359% of patients transitioned to adult focused programs while the rest continued receiving care at Cincinnati Children's — Dr. Julian Goddard
• 0:29Patients who transitioned to adult care had a 33% mortality rate — Dr. Julian Goddard
• 0:29Patients who stayed in pediatric care had a 5% mortality rate — Dr. Julian Goddard
• 0:29The two groups showed no obvious differences in medical complexity or disease burden — Dr. Julian Goddard
• 0:42The median time from transition to death was approximately 12 months — Dr. Julian Goddard
• 0:46Young adults with a history of intestinal failure aging out of pediatric care remain a critically vulnerable population — Dr. Julian Goddard
• 0:46Structured transition programs need to be developed and widely implemented for this population — Dr. Julian Goddard

Open questions

• What specific factors in adult care programs contribute to the increased mortality risk?
• What elements should structured transition programs include to reduce mortality?
• Why does the mortality risk peak within the first 12 months post-transition?